Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OMACETAXINE MEPESUCCINATE for Acute myeloid leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 193 adverse event reports in the FDA FAERS database where OMACETAXINE MEPESUCCINATE was used for Acute myeloid leukaemia.

Most Reported Side Effects for OMACETAXINE MEPESUCCINATE

Side Effect Reports % Deaths Hosp.
Myelosuppression 178 18.6% 7 94
Nausea 154 16.1% 7 43
Platelet count decreased 105 11.0% 5 43
Fatigue 76 7.9% 3 19
Diarrhoea 73 7.6% 4 17
White blood cell count decreased 71 7.4% 3 34
Vomiting 63 6.6% 4 21
Injection site erythema 61 6.4% 1 9
Death 60 6.3% 60 24
Asthenia 57 6.0% 6 22
Pyrexia 56 5.9% 4 36
Headache 47 4.9% 2 7
Neutropenia 43 4.5% 3 16
Haemoglobin decreased 40 4.2% 4 23
Off label use 40 4.2% 4 10

Other Indications for OMACETAXINE MEPESUCCINATE

Chronic myeloid leukaemia (500) Chemotherapy (38) Product used for unknown indication (29) Myelodysplastic syndrome (19) Acute leukaemia (17) Leukaemia (15) Acute promyelocytic leukaemia (13) T-cell type acute leukaemia (13) Philadelphia chromosome positive (10) Acute lymphocytic leukaemia (9)

Other Drugs Used for Acute myeloid leukaemia

VENETOCLAX (19,774) AZACITIDINE (9,065) CYTARABINE (8,295) IDARUBICIN (2,427) DAUNORUBICIN (2,423) ENASIDENIB (2,220) GILTERITINIB (1,963) FLUDARABINE (1,927) MIDOSTAURIN (1,653) DECITABINE (1,400)

Related Pages

OMACETAXINE MEPESUCCINATE Full Profile All Acute myeloid leukaemia Drugs OMACETAXINE MEPESUCCINATE Demographics OMACETAXINE MEPESUCCINATE Timeline